ScoreWhy is Bandaram Pharma Packtech Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.81%
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 7.30 times
2
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 0.76% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -42.71% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Bandaram Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Bandaram Pharma
-42.71%
-0.60
71.16%
Sensex
-2.38%
-0.19
12.70%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
40.50%
EBIT Growth (5y)
50.33%
EBIT to Interest (avg)
1.67
Debt to EBITDA (avg)
6.58
Net Debt to Equity (avg)
1.68
Sales to Capital Employed (avg)
1.19
Tax Ratio
30.59%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
5.75%
ROE (avg)
5.15%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
127
Industry P/E
95
Price to Book Value
3.86
EV to EBIT
41.98
EV to EBITDA
26.97
EV to Capital Employed
2.07
EV to Sales
1.57
PEG Ratio
NA
Dividend Yield
0.05%
ROCE (Latest)
3.88%
ROE (Latest)
1.48%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
NET SALES(Q)
Highest at Rs 14.84 cr
PBDIT(Q)
Highest at Rs 1.01 cr.
PBT LESS OI(Q)
Highest at Rs 0.53 cr.
PAT(Q)
Highest at Rs 0.19 cr.
EPS(Q)
Highest at Rs 0.16
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Bandaram Pharma
Net Sales - Quarterly
At Rs 14.84 cr has Grown at 48.40%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Net Sales - Quarterly
Highest at Rs 14.84 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 1.01 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 0.53 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 0.19 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 0.16
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
